{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:18:20Z","timestamp":1771010300381,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1053\/j.ajkd.2008.05.027","type":"journal-article","created":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T09:57:20Z","timestamp":1217843840000},"page":"412-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Progression of Kidney Disease in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin Versus Usual Care: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)"],"prefix":"10.1053","volume":"52","clinical-trial-number":[{"clinical-trial-number":"nct00000542","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Mahboob","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Baimbridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Barzilay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan N.","family":"Basile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario A.","family":"Henriquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Huml","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Kopyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail T.","family":"Louis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara L.","family":"Pressel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive","family":"Rosendorff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sithiporn","family":"Sastrasinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2008.05.027_bib1","first-page":"S1","article-title":"K\/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.05.027_bib2","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/sj.ki.5001979","article-title":"Dyslipidemia in chronic kidney disease: Causes and consequences","volume":"104","author":"Kaysen","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ajkd.2008.05.027_bib3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.HYP.26.4.670","article-title":"Effects of hypertension and dyslipidemia on the decline in renal function","volume":"26","author":"Manttari","year":"1995","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2008.05.027_bib4","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1681\/ASN.V1482084","article-title":"Cholesterol and the risk of renal dysfunction in apparently healthy men","volume":"14","author":"Schaeffner","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.05.027_bib5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0272-6386(03)00207-5","article-title":"Effect of a 3-year therapy with the 3-hydroxy-3-methylglutaryl coenzyme A reductase-inhibitor fluvastatin on endothelial function and distensibility of large arteries in hypercholesterolemic renal transplant recipient","volume":"41","author":"Kosch","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.05.027_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ndt\/gfi224","article-title":"In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients","volume":"21","author":"Panichi","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2008.05.027_bib7","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1681\/ASN.2004110958","article-title":"Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective?","volume":"16","author":"Campese","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.05.027_bib8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/ajkd.2003.50140","article-title":"A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease","volume":"41","author":"Bianchi","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.05.027_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.HYP.0000022805.11288.7F","article-title":"Effect of pravastatin on proteinuria in patients with well-controlled hypertension","volume":"40","author":"Lee","year":"2002","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2008.05.027_bib10","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/ki.1993.358","article-title":"Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria","volume":"44","author":"Thomas","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.05.027_bib11","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2008.05.027_bib12","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archinte.165.8.936","article-title":"Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"165","author":"Rahman","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2008.05.027_bib13","first-page":"0828A","article-title":"A simplified equation to predict glomerular filtration rate from serum creatinine","volume":"11","author":"Levey","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.05.027_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrica"},{"key":"10.1053\/j.ajkd.2008.05.027_bib15","series-title":"Survival Analysis\u2014Techniques for Censored and Truncated Data","author":"Klein","year":"2003"},{"key":"10.1053\/j.ajkd.2008.05.027_bib16","series-title":"Applied Longitudinal Data Analysis","author":"Singer","year":"2003"},{"key":"10.1053\/j.ajkd.2008.05.027_bib17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.amjcard.2005.09.110","article-title":"Effects of statins on renal function","volume":"97","author":"Agarwal","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.ajkd.2008.05.027_bib18","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1093\/ndt\/gfl244","article-title":"The effect of statins on urinary albumin excretion and glomerular filtration rate: Results from both a randomized clinical trial and an observational cohort study","volume":"21","author":"Atthobari","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2008.05.027_bib19","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1681\/ASN.2006080887","article-title":"Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or angiotensin-converting enzyme inhibitors","volume":"18","author":"Feringa","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.05.027_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF02342442","article-title":"Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy","volume":"35","author":"Hommel","year":"1992","journal-title":"Diabetologia"},{"key":"10.1053\/j.ajkd.2008.05.027_bib21","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/ndt\/17.5.798","article-title":"Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis","volume":"17","author":"Nakamura","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2008.05.027_bib22","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/BF02374502","article-title":"Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria","volume":"36","author":"Nielsen","year":"1993","journal-title":"Diabetologia"},{"key":"10.1053\/j.ajkd.2008.05.027_bib23","first-page":"219","article-title":"A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone","volume":"46","author":"Rayner","year":"1996","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2008.05.027_bib24","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2337\/diacare.20.12.1891","article-title":"Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment","volume":"20","author":"Tonolo","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1053\/j.ajkd.2008.05.027_bib25","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/jcp.2003.012989","article-title":"The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease","volume":"57","author":"Athyros","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.ajkd.2008.05.027_bib26","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3109\/10641969909070853","article-title":"The effect of pravastatin on renal function and lipid metabolism in patients with renal dysfunction with hypertension and hyperlipidemia","volume":"21","author":"Imai","year":"1999","journal-title":"Clin Exp Hypertens"},{"key":"10.1053\/j.ajkd.2008.05.027_bib27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/BF00400731","article-title":"Cholesterol-lowering therapy may retard the progression of diabetic nephropathy","volume":"38","author":"Lam","year":"1995","journal-title":"Diabetologia"},{"key":"10.1053\/j.ajkd.2008.05.027_bib28","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1159\/000065021","article-title":"Impact of treatment of dyslipidemia on renal function, fat deposits and scarring in patients with persistent nephrotic syndrome","volume":"91","author":"Gheith","year":"2002","journal-title":"Nephron"},{"key":"10.1053\/j.ajkd.2008.05.027_bib29","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.ASN.0000068461.45784.2F","article-title":"Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease","volume":"14","author":"Tonelli","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.05.027_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.104.517565","article-title":"Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2008.05.027_bib31","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1681\/ASN.2006010012","article-title":"Statins for improving renal outcomes: A meta-analysis","volume":"17","author":"Sandhu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.05.027_bib32","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmj.39472.580984.AE","article-title":"Effects of statins in patients with chronic kidney disease: Meta-analysis and meta-regression of randomised controlled trials","volume":"336","author":"Strippoli","year":"2008","journal-title":"BMJ"},{"key":"10.1053\/j.ajkd.2008.05.027_bib33","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.ajkd.2008.05.027_bib34","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.0000143892.84582.60","article-title":"Effect of pravastatin on cardiovascular events in people with chronic kidney disease","volume":"110","author":"Tonelli","year":"2004","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2008.05.027_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.7326\/0003-4819-145-2-200607180-00009","article-title":"Meta-analysis: The effect of statins on albuminuria","volume":"145","author":"Douglas","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2008.05.027_bib36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.drudis.2006.03.017","article-title":"An overview of statin-associated proteinuria","volume":"11","author":"Tiwari","year":"2006","journal-title":"Drug Discov Today"},{"key":"10.1053\/j.ajkd.2008.05.027_bib37","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1046\/j.1523-1755.63.s84.4.x","article-title":"Study of Heart and Renal Protection (SHARP)","volume":"84","author":"Baigent","year":"2003","journal-title":"Kidney Int Suppl"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608009992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608009992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:49:46Z","timestamp":1759456186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638608009992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0272638608009992"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.05.027","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progression of Kidney Disease in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin Versus Usual Care: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.07.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}